These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23831280)

  • 21. Multiple drug resistance and strength of attachment to surfaces in Pseudomonas aeruginosa isolates.
    Haddadin RN; Saleh SA; Mahmoud RA; Shehabi AA
    Lett Appl Microbiol; 2010 Jul; 51(1):48-53. PubMed ID: 20477963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections.
    Epstein SP; Bottone EJ; Asbell PA
    Eye Contact Lens; 2006 Sep; 32(5):240-4. PubMed ID: 16974157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of resistance to fluoroquinolones in clinical and environmental isolates of Pseudomonas aeruginosa.
    Prasad SV; Ballal M; Shivananda PG
    Indian J Pathol Microbiol; 2007 Jan; 50(1):94-6. PubMed ID: 17474274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality control of decontaminating agents.
    Arancegui N; Cabanillas M; Martinez A; Funosas E; Maestri L; Hermida Lucena P
    Acta Odontol Latinoam; 1999; 12(2):83-8. PubMed ID: 12905908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year report of national surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea (2002-2006).
    Yoo J; Sohn ES; Chung GT; Lee EH; Lee KR; Park YK; Lee YS
    Diagn Microbiol Infect Dis; 2008 Mar; 60(3):291-4. PubMed ID: 18068936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disinfectant Susceptibility Profiling of Glutaraldehyde-Resistant Nontuberculous Mycobacteria.
    Burgess W; Margolis A; Gibbs S; Duarte RS; Jackson M
    Infect Control Hosp Epidemiol; 2017 Jul; 38(7):784-791. PubMed ID: 28462746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections.
    Suárez C; Peña C; Tubau F; Gavaldà L; Manzur A; Dominguez MA; Pujol M; Gudiol F; Ariza J
    J Infect; 2009 Apr; 58(4):285-90. PubMed ID: 19297028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural antimicrobial agent (reuterin) produced by lactobacillus reuteri for sanitization of biological tissues inoculated with pseudomonas aeruginosa.
    Liang HF; Chen CN; Chang Y; Sung HW
    Biotechnol Bioeng; 2003 Oct; 84(2):233-9. PubMed ID: 12966580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Discrepancy in the disk diffusion susceptibility test of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients after anaerobic preincubation and its potential clinical relevance].
    Cafini F; García-Rey C; Bas P; Gómez-Lus ML; Sánchez I; Vázquez S; Prieto J
    Rev Esp Quimioter; 2012 Dec; 25(4):269-73. PubMed ID: 23303259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic and metal resistance among hospital and outdoor strains of Pseudomonas aeruginosa.
    Deredjian A; Colinon C; Brothier E; Favre-Bonté S; Cournoyer B; Nazaret S
    Res Microbiol; 2011 Sep; 162(7):689-700. PubMed ID: 21726631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological characterization of human and environmental Pseudomonas aeruginosa strains: use of plasmid pattern analysis in addition to other typing methods.
    Orsi N; Mansi A; Orsi GB; Tomao P; Foresti E; Visca P
    Ann Ig; 1994; 6(4-6):653-64. PubMed ID: 8611240
    [No Abstract]   [Full Text] [Related]  

  • 32. Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.
    Wolter DJ; Acquazzino D; Goering RV; Sammut P; Khalaf N; Hanson ND
    Clin Infect Dis; 2008 Jun; 46(12):e137-41. PubMed ID: 18462098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
    Turner PJ
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa.
    Gelfand MS; Cleveland KO; Mazumder SA
    J Antimicrob Chemother; 2009 Jun; 63(6):1297-9. PubMed ID: 19369268
    [No Abstract]   [Full Text] [Related]  

  • 35. Antimicrobial susceptibility of Pseudomonas aeruginosa in China: a review of two multicentre surveillance programmes, and application of revised CLSI susceptibility breakpoints.
    Xiao M; Wang Y; Yang QW; Fan X; Brown M; Kong F; Xu YC
    Int J Antimicrob Agents; 2012 Nov; 40(5):445-9. PubMed ID: 22910455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between fluoroquinolone consumption in hospitals and ciprofloxacin resistance amongst Pseudomonas aeruginosa isolates causing healthcare-associated infections, Taiwan, 2000-2009.
    Weng TC; Chen YH; Lee CC; Wang CY; Lai CC; Tang HJ; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2011 Jun; 37(6):581-4. PubMed ID: 21489757
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Susceptibility and resistence of Pseudomonas aeruginosa to antimicrobial agents].
    Gamero Delgado MC; García-Mayorgas AD; Rodríguez F; Ibarra A; Casal M
    Rev Esp Quimioter; 2007 Jun; 20(2):230-3. PubMed ID: 17893761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudomonas aeruginosa biofilms in hospital water systems and the effect of sub-inhibitory concentration of chlorine.
    Suman E; Singh S; Kotian S
    J Hosp Infect; 2008 Oct; 70(2):199-201. PubMed ID: 18723254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.